IV Fluids
Our portfolio contains the following IV Fluids:
- 0.9% Sodium Chloride Intravenous Infusion Solution. Presentations: 50ml bags, 100ml bags, 250ml bags, 500ml bags, 1000ml bags. PA0931/001/001
- 5% Glucose Intravenous Infusion Solution. Presentations: 50ml bags, 100ml bags, 250ml bags, 500ml bags, 1000ml bags. PA0931/002/001.
- Sodium Chloride 0.18% w/v Glucose 4%w/v Solution for infusion. Presentations: 500ml bags, 1000ml bags. PA0931/004/001.
- Potassium Chloride 0.15%w/v Sodium Chloride 0.9%w/v Solution for Infusion. Presentations: 500ml bags, 1000ml bags. PA0931/007/001
- Potassium Chloride 0.15%w/v Glucose 5%w/v Solution for Infusion. Presentations: 500ml bags, 1000ml bags. PA0931/006/002
- Potassium Chloride 0.15%w/v Sodium Chloride 0.18%w/v Glucose 4%w/v Solution for Infusion. Presentations: 500ml bags, 1000ml bags. PA0931/008/001.
- Potassium Chloride 0.3%w/v Sodium Chloride 0.18%w/v Glucose 4%w/v Solution for Infusion. Presentations: 500ml bags, 1000ml bags. PA0931/008/002
- Potassium Chloride 0.3% w/v Sodium Chloride 0.9% w/v Solution for Infusion. Presentations: 500ml bags, 1000ml bags. PA0931/005/001
- Potassium Chloride 0.3%w/v Glucose 5%w/v Solution for Infusion. Presentations: 500ml bags, 1000ml bags. PA0931/006/001.
- Hartmann’s Solution Compound Sodium Lactate Intravenous Infusion BP. Presentations: 1000ml bags, 500ml bags. PA0931/009/003.
Fannin Ltd in partnership with Macopharma have a wide portfolio of IV Fluids available to customers in Ireland. (This link will take you to a non-Fannin Ltd. website. Fannin Ltd. does not recommend, endorse or accept liability for sites controlled by third-parties.)
Method of Sale: POM
MAH Holder: Maco Pharma (UK) Ltd, 8th Floor- Regal House, 70 London Road, Twickenham, Middlesex, TW1 3QS, United Kingdom
For any further information please speak to your local Fannin Representative or contact our medical information department for a copy of the SPC at medical@dccvital.com or via phone on 0868394447
Full prescribing information available on request.
IE2018/015/00
Date of preparation: March 2018